Found: 2
Select item for more details and to access through your institution.
Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 207, p. 1, doi. 10.1126/scitranslmed.3006479
- By:
- Publication type:
- Article
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
- Published in:
- Nature, 2012, v. 492, n. 7427, p. 108, doi. 10.1038/nature11606
- By:
- Publication type:
- Article